Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 68788-7757 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

gabapentin 800mg 500tab

gabapentin 800mg 500tab

Gabapentin is a medication that comes in a tablet form of 800mg and is used as a prescription for patients only, as per Federal Law. The tablets are generic for Neurontin Gabapentin Tablets, USP 800mg and manufactured by ScieGen Pharmaceuticals. The tablets should be stored at a temperature range of 20°C to 25°C (68°F to T1°F) away from the reach of children. The packaging contains important information such as lot number, batch number, and the expiration date. The tablets are white in color and imprinted with "11/8 G".*

Figure 1 - image 01

Figure 1 - image 01

This text represents a chart that shows the mean pain score for different treatment methods over a period of weeks. The treatment methods include a placebo and gabapentin at a dose of 3600mg/day, with two different dose titration periods. The chart shows the baseline and pain scores at four weeks.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph showing the mean pain score over a 4-week fixed dose period for participants taking a placebo or gabapentin at either 1800mg/day or 2400mg/day. The X-axis shows the weeks and the Y-axis shows the pain score.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.